| Financial Year |
March 31 2023 |
| Monetary Funds |
541,402,752.39 |
| Held-for-trading Financial Assets |
213,173,811.20 |
| Notes Receivable |
-- |
| Accounts Receivable |
39,666,666.09 |
| Advances to Suppliers |
20,659,363.78 |
| Other Receivables |
28,516,669.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,868,788,041.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
107,792,604.87 |
| Total Current Assets |
3,819,999,908.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,199,351,616.91 |
| Investment Properties |
1,268,453,883.68 |
| Fixed Assetes |
3,494,208,470.11 |
| Under-construction Projects |
257,370,321.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
146,372,616.28 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
452,913,732.54 |
| R&D expenses |
-- |
| Goodwill |
46,426,545.82 |
| Long-Term Deferred and Prepaid Expenses |
71,300,070.88 |
| Deferred Income Tax Assets |
100,530,007.69 |
| Other Non-Current Assets |
638,979,997.09 |
| Sub-Total of Non-Current Assets |
8,394,493,683.10 |
| Total Assets |
12,214,493,591.99 |
| Short-Term Loans |
121,299,684.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,046,000,930.36 |
| Accounts Received In Advance |
23,509,512.10 |
| Employee Compensation Payable |
73,576,882.55 |
| Taxes Payable |
81,249,925.61 |
| Interest Payable |
-- |
| Dividend Payable |
2,788,805.00 |
| Other payables |
260,583,766.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
560,119,616.50 |
| Other Current Liabilities |
188,675,045.59 |
| Sub-Total of Current Liabilities |
4,213,837,678.93 |
| Long-term Loans |
2,009,025,990.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,093,519.45 |
| Deferred Income Tax Liabilities |
277,383,389.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,117,528,020.19 |
| Total Liabilities |
7,331,365,699.12 |
| Paid-In Capital(Or Share Stock) |
1,151,513,578.00 |
| Capital Surplus |
1,627,646,201.29 |
| Surplus Reserve |
238,499,161.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
859,633,675.02 |
| Minority Stockholder's Interest |
490,923,372.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,392,204,520.22 |
| Owner's Equity（Stockholder's Equity） |
4,883,127,892.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,214,493,591.99 |
